Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR

Featuring perspectives from Dr Ibiayi Dagogo-Jack and Dr Corey J Langer, including the following topics:

• Introduction: A Model for Targeted Treatment in Non-Small Cell Lung Cancer (NSCLC) (0:00)
• NSCLC with ALK, ROS1 and NTRK Rearrangements — Dr Langer (9:10)
• Current and Future Treatment of Metastatic NSCLC with RET, MET, HER2 and KRAS Alterations — Dr Dagogo-Jack (34:22)

CME information and select publications